CSEC Trademark

Trademark Overview

On Wednesday, June 19, 2013, a trademark application was filed for CSEC with the United States Patent and Trademark Office. The USPTO has given the CSEC trademark a serial number of 79134461. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Monday, June 19, 2023. This trademark is owned by SHIN NIPPON BIOMEDICAL LABORATORIES, LTD.. The CSEC trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Scientific research; research and development in the field of medical technology; testing, inspection, analysis or research of pharmaceutical products; providing information regarding testing, inspection or research of pharmaceutical products, and consulting thereof; conducting clinical trials for others for pharmaceutical products; providing information regarding clinical trials for others for pharmaceutical products
csec

General Information

Serial Number79134461
Word MarkCSEC
Filing DateWednesday, June 19, 2013
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateMonday, June 19, 2023
Registration Number4493165
Registration DateTuesday, March 11, 2014
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, December 24, 2013

Trademark Statements

Description of MarkThe mark consists of the letters "CSEC" in the color white inside a heart that is with a line going up and down across the bottom of the heart. The middle of the heart is divided with a line like a puzzle piece.
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesScientific research; research and development in the field of medical technology; testing, inspection, analysis or research of pharmaceutical products; providing information regarding testing, inspection or research of pharmaceutical products, and consulting thereof; conducting clinical trials for others for pharmaceutical products; providing information regarding clinical trials for others for pharmaceutical products

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, February 26, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSHIN NIPPON BIOMEDICAL LABORATORIES, LTD.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressJP
Party NameSHIN NIPPON BIOMEDICAL LABORATORIES, LTD.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressJP
Party NameSHIN NIPPON BIOMEDICAL LABORATORIES, LTD.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressJP

Trademark Events

Event DateEvent Description
Friday, January 12, 2024NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Friday, January 12, 2024DEATH OF INTERNATIONAL REGISTRATION
Sunday, April 3, 2022TOTAL INVALIDATION PROCESSED BY THE IB
Friday, February 25, 2022TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Friday, February 25, 2022INVALIDATION PROCESSED
Tuesday, October 26, 2021TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, February 26, 2021CANCELLED SECTION 71
Thursday, July 31, 2014FINAL DECISION TRANSACTION PROCESSED BY IB
Tuesday, July 15, 2014FINAL DISPOSITION NOTICE SENT TO IB
Tuesday, July 15, 2014FINAL DISPOSITION PROCESSED
Wednesday, June 11, 2014FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, March 11, 2014REGISTERED-PRINCIPAL REGISTER
Tuesday, December 24, 2013NOTIFICATION PROCESSED BY IB
Tuesday, December 24, 2013PUBLISHED FOR OPPOSITION
Wednesday, December 4, 2013NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, December 4, 2013NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, December 4, 2013NOTICE OF PUBLICATION
Tuesday, November 19, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, November 13, 2013ASSIGNED TO LIE
Friday, October 25, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, October 21, 2013REFUSAL PROCESSED BY IB
Wednesday, October 16, 2013TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, October 16, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, October 16, 2013TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, October 1, 2013NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, October 1, 2013REFUSAL PROCESSED BY MPU
Sunday, September 29, 2013NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Saturday, September 28, 2013NON-FINAL ACTION WRITTEN
Friday, September 27, 2013ASSIGNED TO EXAMINER
Tuesday, August 27, 2013APPLICATION FILING RECEIPT MAILED
Wednesday, August 21, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, August 16, 2013LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, August 15, 2013SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

csec products pharmaceutical research regarding clinical trials others information providing testing